IRIS
DE MARCHI, Fabiola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.668
AS - Asia 2.916
NA - Nord America 2.902
SA - Sud America 367
AF - Africa 184
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 10.045
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.760
RU - Federazione Russa 1.130
SG - Singapore 1.091
IE - Irlanda 620
IT - Italia 620
CN - Cina 546
HK - Hong Kong 363
VN - Vietnam 358
DE - Germania 353
BR - Brasile 273
SE - Svezia 247
FR - Francia 180
BD - Bangladesh 128
BJ - Benin 115
GB - Regno Unito 103
KR - Corea 95
UA - Ucraina 94
IN - India 92
CA - Canada 77
FI - Finlandia 53
JP - Giappone 49
PL - Polonia 44
MX - Messico 43
NL - Olanda 41
TR - Turchia 38
AR - Argentina 36
AT - Austria 35
ID - Indonesia 30
ZA - Sudafrica 28
ES - Italia 25
EE - Estonia 21
IR - Iran 21
CZ - Repubblica Ceca 19
IQ - Iraq 18
DK - Danimarca 14
CL - Cile 13
EC - Ecuador 13
LT - Lituania 13
RO - Romania 12
AE - Emirati Arabi Uniti 11
JO - Giordania 11
BE - Belgio 10
DZ - Algeria 10
CO - Colombia 9
PK - Pakistan 9
VE - Venezuela 8
CH - Svizzera 7
MA - Marocco 7
MY - Malesia 7
PH - Filippine 7
TN - Tunisia 7
PY - Paraguay 6
DO - Repubblica Dominicana 5
GR - Grecia 5
JM - Giamaica 5
LB - Libano 5
TH - Thailandia 5
UZ - Uzbekistan 5
AU - Australia 4
KE - Kenya 4
LV - Lettonia 4
NP - Nepal 4
PE - Perù 4
SA - Arabia Saudita 4
BO - Bolivia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
AO - Angola 2
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
CY - Cipro 2
HU - Ungheria 2
KZ - Kazakistan 2
NG - Nigeria 2
RS - Serbia 2
SI - Slovenia 2
UY - Uruguay 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 10.031
Salva come PNG Salva come JPEG
Città #
Dublin 616
San Jose 377
Singapore 370
Hong Kong 359
Ashburn 273
Beijing 180
Los Angeles 147
Jacksonville 143
Council Bluffs 137
Moscow 122
Ho Chi Minh City 118
Cotonou 115
Lauterbourg 103
Seoul 90
New York 74
Munich 70
Chandler 67
Hanoi 64
Buffalo 59
Dallas 58
Dearborn 58
Novara 57
Rome 55
Turin 53
Milan 49
Santa Clara 47
Orem 46
Mülheim 44
Frankfurt am Main 40
Lawrence 35
Princeton 35
Boardman 34
Falkenstein 32
São Paulo 32
Wilmington 32
Tokyo 31
Warsaw 31
Helsinki 29
Chennai 28
Stockholm 27
Toronto 26
Bremen 24
Nuremberg 24
Strasbourg 24
Amsterdam 23
Montreal 23
Houston 22
Mexico City 22
Phoenix 22
Brooklyn 21
Johannesburg 21
Denver 19
Vienna 19
Columbus 18
London 18
Atlanta 17
San Mateo 17
Seattle 17
The Dalles 16
Brno 15
Da Nang 15
Poplar 15
Vercelli 15
Ankara 14
Hangzhou 14
Piemonte 14
Rio de Janeiro 14
Chicago 13
Jakarta 13
Manchester 13
Tianjin 13
Redondo Beach 12
Turku 12
Zanjan 12
Amman 11
Haiphong 11
Tornaco 11
Boston 10
Brussels 10
Guangzhou 10
Monmouth Junction 10
Mumbai 10
San Francisco 10
St Louis 10
Hillsboro 9
Hải Dương 9
Kocmyrzów 9
Villadossola 9
Dhaka 8
Kocaeli 8
New Delhi 8
Ottawa 8
Baghdad 7
Borgomanero 7
Querétaro 7
Santiago 7
Zurich 7
Ann Arbor 6
Augusta 6
Cassano Magnago 6
Totale 5.158
Salva come PNG Salva come JPEG
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 246
Retrospective observational study on the use of acetyl-L-carnitine in ALS 189
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 178
Advances in stem cell therapy for amyotrophic lateral sclerosis 174
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 161
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 158
A case of marchiafava bignami disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms 139
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 133
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 130
Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem 124
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 122
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 122
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 121
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 120
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 119
Headache in immigrant patients: similarities and differences with Italian population 118
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 117
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 116
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 113
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 113
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies 112
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 110
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 109
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 109
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson’s disease 109
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 107
null 105
Effects of Acetyl-L-Carnitine on Oxidative Stress in Amyotrophic Lateral Sclerosis Patients: Evaluation on Plasma Markers and Members of the Neurovascular Unit 103
Frontotemporal Dementia Presenting as Gambling Disorder: When a Psychiatric Condition Is the Clue to a Neurodegenerative Disease 103
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 100
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 99
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 98
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 98
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 97
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 96
C9ORF72 Repeat Expansion Affects the Proteome of Primary Skin Fibroblasts in ALS 95
Depression and risk of Cognitive Dysfunctions in Amyotrophic Lateral Sclerosis 95
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 94
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 94
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 94
Circulating GLAST+ EVs are increased in amyotrophic lateral sclerosis 92
A pilot trial of RNS60 in amyotrophic lateral sclerosis 92
Occipital Neuralgia in Chiari I Malformation: Two Different Events or Two Different Faces of the Same Event? 92
Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity 91
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 90
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 89
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 86
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 85
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 84
Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry 83
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 83
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 82
Marchiafava-Bignami Disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms: A case report 82
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 81
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 81
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 80
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients 80
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 79
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses 78
Challenging the boundaries: c9orf72 mutation presenting as Alzheimer's disease 78
Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment 78
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 77
Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis 75
Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis 74
Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis 74
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine 74
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19 74
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 72
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients 72
Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis 71
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 71
Profiling cognition and brain metabolism in amyotrophic lateral sclerosis and frontotemporal dementia 71
Telehealth in neurodegenerative diseases: Opportunities and challenges for patients and physicians 71
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review 71
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients 69
Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond 69
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents 69
Identification of Transcriptomic Differences in Induced Pluripotent Stem Cells and Neural Progenitors from Amyotrophic Lateral Sclerosis Patients Carrying Different Mutations: A Pilot Study 69
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 69
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 66
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 65
Exploring the phenotypic fingerprints of ANXA11 variants in ALS: a population-based study in an European cohort 64
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder 64
Cell therapy in ALS: An update on preclinical and clinical studies 62
From Mild Cognitive Impairment to Dementia: The Impact of Comorbid Conditions on Disease Conversion 62
Editorial: What's next? Innovative translational markers across the ALS-FTD continuum 62
The diagnostic and prognostic role of biomarkers for amyotrophic lateral sclerosis 62
Predicting Cognitive Decline in Parkinson's Disease: Can We Ask the Genes? 62
What is amyotrophic lateral sclerosis prevalence? 61
Croplands proximity is associated with amyotrophic lateral sclerosis incidence and age at onset 60
From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We? 60
Clinical trials in pediatric ALS: a TRICALS feasibility study 59
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale 58
Variability in Clinical Phenotype in TARDBP Mutations: Amyotrophic Lateral Sclerosis Case Description and Literature Review 58
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders 58
Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis 56
Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis 56
Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: A New Frontier for Targeting? 55
The role of peripheral immunity in ALS: a population‐based study 54
Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort 53
Totale 9.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.333
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/2022304 20 11 15 26 16 7 2 7 23 16 73 88
2022/20231.230 45 56 40 10 82 88 46 54 667 17 98 27
2023/2024571 50 38 80 29 82 20 76 5 13 5 50 123
2024/20251.855 45 38 125 36 50 196 120 164 339 172 168 402
2025/20265.667 289 206 288 687 669 405 748 881 369 449 417 259
Totale 10.243